Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol in Cardiac EP Studies
NCT06700681Enrolling by invitation
- Sponsor
- Taipei Veterans General Hospital
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of remimazolam in cardiac arrhythmia (4 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Hemodynamic stability--Vasopressor dosage. Started Sep 2024; status: enrolling by invitation.
02
Drugs
remimazolam
03
Conditions
cardiac arrhythmia
Beyond the preview
Go deeper on NCT06700681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06700681.